PD-L1 Testing and Assessment: Practical Considerations for Oncologist and Pathologist

被引：0
|
作者：
Pasricha, Sunil [1 ]
Durga, Garima [1 ,5 ]
Koyyala, Venkata Pradeep Babu [2 ]
Jajodia, Ankush [3 ]
Gupta, Gurudutt [1 ]
Mehta, Anurag [4 ]
机构：
[1] Rajiv Gandhi Canc Inst & Res Ctr, Dept Pathol, Delhi, India
[2] Assam Canc Care Fdn, Tezpur Canc Ctr, Dept Med Oncol, Gauhati, Assam, India
[3] McMaster Univ, Juravinski Hosp, Dept Radiol, Hamilton, ON, Canada
[4] Rajiv Gandhi Canc Inst & Res Ctr, Lab Serv & Res, Delhi, India
[5] Rajiv Gandhi Canc Inst & Res Ctr, Pathol Dept, Sect 5, Delhi 110085, India
来源：
INDIAN JOURNAL OF MEDICAL AND PAEDIATRIC ONCOLOGY | 2024年 / 45卷 / 02期
关键词：
D O I：
10.1055/s-0042-1748797
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：157 / 162
页数：6
相关论文
共 50 条
  • [41] Prospective multi-institutional evaluation of pathologist assessment of PD-L1 assays for patient selection in triple negative breast cancer
    Reisenbichler, Emily S.
    Han, Gang
    Bellizzi, Andrew
    Bossuyt, Veerle
    Brock, Jane
    Cole, Kimberly
    Fadare, Oluwole
    Hameed, Omar
    Hanley, Krisztina
    Harrison, Beth T.
    Kuba, M. Gabriela
    Ly, Amy
    Miller, Dylan
    Podoll, Mirna
    Roden, Anja C.
    Singh, Kamaljeet
    Sanders, Mary Ann
    Wei, Shi
    Wen, Hannah
    Pelekanou, Vasiliki
    Yaghoobi, Vesal
    Ahmed, Fahad
    Pusztai, Lajos
    Rimm, David L.
    MODERN PATHOLOGY, 2020, 33 (09) : 1746 - 1752
  • [42] PD-L1 assessment in pediatric rhabdomyosarcoma: a pilot study
    Bertolini, Giulia
    Bergamaschi, Luca
    Ferrari, Andrea
    Renne, Salvatore L.
    Collini, Paola
    Gardelli, Cecilia
    Barisella, Marta
    Centonze, Giovanni
    Chiaravalli, Stefano
    Paolino, Cinzia
    Milione, Massimo
    Massimino, Maura
    Casanova, Michela
    Gasparini, Patrizia
    BMC CANCER, 2018, 18
  • [43] PD-L1 assessment in pediatric rhabdomyosarcoma: a pilot study
    Giulia Bertolini
    Luca Bergamaschi
    Andrea Ferrari
    Salvatore L. Renne
    Paola Collini
    Cecilia Gardelli
    Marta Barisella
    Giovanni Centonze
    Stefano Chiaravalli
    Cinzia Paolino
    Massimo Milione
    Maura Massimino
    Michela Casanova
    Patrizia Gasparini
    BMC Cancer, 18
  • [44] Diagnostic Accuracy in Fit-for-Purpose PD-L1 Testing
    Cheung, Carol C.
    Lim, Hyun J.
    Garratt, John
    Won, Jennifer
    Gilks, C. Blake
    Torlakovic, Emina E.
    APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2019, 27 (04) : 251 - 257
  • [45] Adequacy of Endobronchial Ultrasound (EBUS) for PD-L1 Expression Testing
    Somalaraju, S.
    Naqvi, S.
    Sood, R.
    Dugan, J.
    Lamb, C. R.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2019, 199
  • [46] Harmonization of PD-L1 testing in oncology: a Canadian pathology perspective
    Ionescu, D. N.
    Downes, M. R.
    Christofides, A.
    Tsao, M. S.
    CURRENT ONCOLOGY, 2018, 25 (03) : E209 - E216
  • [47] PD-L1 Testing and Clinical Benefit in Patients Treated with CPI
    Kovacevic, M.
    Ivanovic, M.
    Kern, I.
    Cufer, T.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S781 - S782
  • [48] Role of Pleural Fluid Molecular Markers and PD-L1 Testing
    Lohinai, Z.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S73 - S73
  • [49] PD-L1 Testing in Cancer Challenges in Companion Diagnostic Development
    Hansen, Aaron R.
    Siu, Lillian L.
    JAMA ONCOLOGY, 2016, 2 (01) : 15 - 16
  • [50] Will Testing for Tumor Mutational Burden Bring the Same Challenges as Testing for PD-L1?
    Gupta V.
    Ramirez M.C.
    Schauser L.
    Genetic Engineering and Biotechnology News, 2019, 39 (06): : 56 - 57
12345